New Delhi: The findings from a crucial clinical trial that may transform hypertension management in India have shown that two-drug combinations of three widely used medicines used in patients with high …
New Delhi: Over 60 percent fixed-dose combination (FDC) drugs consumed for mental health disorders in India are “unapproved” and lack therapeutic benefit, an analysis has found amid a major crackdown on …
New Delhi: A molecule developed fully in India, enmetazobactam, which has gone on to become the first-ever internationally approved “new drug” from the country as part of an antibiotic fixed …
New Delhi: India’s apex drug regulator, the Central Drugs Standard Control Organisation (CDSCO), last month instructed drugmakers not to sell a popular fixed dose combination (FDC) medicine, indicated as a …
New Delhi: India’s apex drug regulator has given conditional approval to continue the manufacture and sale of five fixed-dose combination (FDC) medicines, asking drugmakers to produce post-marketing safety and efficacy data …
New Delhi: Government initiatives to remove centrally unapproved and banned antibiotic fixed-dose combination (FDC) drugs have remained largely ineffective, and in 2020, most of the antibiotic formulations sold in India …